Cullinan Therapeutics Inc (NAS:CGEM)
$ 19.58 +1.27 (+6.94%) Market Cap: 1.26 Bil Enterprise Value: 927.60 Mil PE Ratio: 0 PB Ratio: 3.74 GF Score: 22/100

Cullinan Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 06:10 PM GMT
Release Date Price: $15.73 (-1.63%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CGEM.OQ - Cullinan Therapeutics Inc
Cullinan Therapeutics Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 06:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, welcome back to the forty-sixth annual TD Cowan Healthcare Conference.

Mark Fram from the biotech team here at TD Cowan, really pleased to have with us for the next session here, the team from Cullen and Therapeutics. We've got Nadine, Nadeem Ahmed, President and CEO, as well as Jeff Jones, who is the CMO. And we will go through a whole list of questions that, me and my colleague, Ellen have come up with, but also feel free to raise your hand, and we will TRY to involve the audience if you have your own questions that you want to follow-up with or anything. But with that, maybe Nadeem, to start out with, you want to kind of give a high level state of the company status update and kind of what
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot